Related Experiment Video

Updated: Apr 23, 2026

In Vitro Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease
10:16

In Vitro Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease

Published on: December 20, 2017

7.6K

Glutaric aciduria type 1--importance of early diagnosis and treatment

Bushra Afroze, Zabedah Mohammad Yunus

    JPMA. the Journal of the Pakistan Medical Association
    |October 3, 2014
    PubMed

    Insights

    Early diagnosis of glutaric aciduria type 1 via newborn screening is crucial. Prompt metabolic treatment prevents neurological damage and ensures normal growth, unlike late diagnosis.

    Area of Science:

    • Biochemistry
    • Genetics
    • Pediatrics

    Background:

    • Glutaric aciduria type 1 (GA1) is a rare inherited metabolic disorder.
    • Untreated GA1 leads to severe neurological damage, particularly dystonia, in early childhood, causing high morbidity and mortality.

    Observation:

    • This study presents two siblings with GA1, exhibiting divergent long-term outcomes.
    • The first child, diagnosed late, suffered severe neurological damage.
    • The second child, identified through neonatal high-risk screening, received timely treatment and achieved normal growth.

    Findings:

    • Neonatal diagnosis of GA1 allows for preventative metabolic treatment, including dietary management and supplementation.
    • Early intervention effectively prevents the characteristic striatal injury and subsequent neurological deficits.
    • Delayed diagnosis significantly limits treatment efficacy, as neurological damage is often irreversible.

    Implications:

    • GA1 inclusion in newborn screening panels is vital for early detection and intervention.
    • Timely metabolic treatment can avert severe neurological sequelae, improving patient outcomes.
    • This case highlights the critical importance of early diagnosis and management in inherited metabolic diseases.

    More Related Videos

    Characterization of Metabolic Status in Nonhuman Primates with the Intravenous Glucose Tolerance Test06:59

    Characterization of Metabolic Status in Nonhuman Primates with the Intravenous Glucose Tolerance Test

    Published on: November 13, 2016

    10.5K
    Electrochemiluminescence Assays for Human Islet Autoantibodies09:15

    Electrochemiluminescence Assays for Human Islet Autoantibodies

    Published on: March 23, 2018

    15.9K

    Related Concept Videos

    Inborn Errors of Metabolism01:20

    Inborn Errors of Metabolism

    Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
    1.1K
    Type I Diabetes I: Introduction01:12

    Type I Diabetes I: Introduction

    Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1...
    18
    Glucose Transporters01:27

    Glucose Transporters

    Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
    Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
    15.1K
    Type I Diabetes III: Clinical Manifestations01:19

    Type I Diabetes III: Clinical Manifestations

    Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the...
    12
    Diabetes Mellitus: Overview and Type I Subtype01:22

    Diabetes Mellitus: Overview and Type I Subtype

    Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
    Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
    5.3K
    Diabetes: Symptoms, Diagnosis, and Complications01:15

    Diabetes: Symptoms, Diagnosis, and Complications

    For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
    2.5K